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This review will highlight a variety of mechanisms by which neurosteroids affect sensitivity
to ethanol, including physiological states associated with activity of the hypothalamic–
pituitary–adrenal (HPA) and hypothalamic–pituitary–gonadal (HPG) axes, and the effects of
chronic exposure to ethanol, in addition to behavioral implications. To date, γ-aminobutyric
acid (GABAA) receptor mechanisms are a major focus of the modulation of ethanol effects
by neuroactive steroids.While NMDA receptor mechanisms are gaining prominence in the
literature, these complex data would be best discussed separately. Accordingly, GABAA
receptor mechanisms are emphasized in this review with brief mention of some NMDA
receptor mechanisms to point out contrasting neuroactive steroid pharmacology. Over-
all, the data suggest that neurosteroids are virtually ubiquitous modulators of inhibitory
neurotransmission. Neurosteroids appear to affect sensitivity to ethanol in speciﬁc brain
regions and, consequently, speciﬁc behavioral tests, possibly related to the efﬁcacy and
potency of ethanol to potentiate the release of GABA and increase neurosteroid concentra-
tions. Although direct interaction of ethanol and neuroactive steroids at common receptor
binding sites has been suggested in some studies, this proposition is still controversial. It
is currently difﬁcult to assign a speciﬁc mechanism by which neuroactive steroids could
modulate the effects of ethanol in particular behavioral tasks.
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BACKGROUND
In the brain, fast inhibitory electrical signaling is mediated pri-
marily by the family of γ-aminobutyric acid (GABA)A receptors,
making them important modulators of all neural processing.
Harrison and Simmonds (1984) provided the ﬁrst clear evi-
dence that neuroactive steroids act at speciﬁc neurotransmitter
receptors, investigating the ability of alphaxalone (3α-hydroxy-5α-
pregnane l l,20-dione) to potentiate responses at GABAA recep-
tors induced by muscimol in cortical slices. Within 2 years, a
progesterone metabolite (3α-hydroxy-5α-pregnan-20-one, 3α,5α-
THP, allopregnanolone) and a deoxycorticosterone metabolite
(3α,21-dihydroxy-5α-pregnan-20-one, 3α,5α-THDOC, tetrahy-
drodeoxycorticosterone) were shown to be positive modulators
of GABAA receptors (Majewska et al., 1986). That same year,
publications showed that ethanol has direct action at GABAA
receptors (Allan and Harris, 1986; Suzdak et al., 1986). Thus,
the GABAA receptor complex was identiﬁed as a membrane-
bound target providing a pharmacological basis for shared sensi-
tivity betweenneurosteroids and ethanol. The commonbehavioral
effects of ethanol and neuroactive steroids were compared directly
using drug discrimination procedures (Ator et al., 1993). The
N -methyl-d-aspartate (NMDA) receptor complex, a membrane-
bound ionophore important for excitatory glutamate neurotrans-
mission, was shown to be antagonized by low concentrations of
ethanol (Lovinger et al., 1989). Soon, data was showing that neu-
rosteroids act at NMDA receptors (Wu et al., 1991). Thus, by the
mid-1990s, the stage was set for the suggestion that neurosteroids,
and physiological states that alter circulating neuroactive steroids,
could affect sensitivity to ethanol (Grant et al., 1997).
NEUROACTIVE STEROIDS MODULATE
NEUROTRANSMISSION IN AN ISOMERIC-DEPENDENT
MANNER
Neuroactive steroids are produced in peripheral organs, includ-
ing testes, ovaries, adrenal glands, lung, and liver, but can cross
the blood–brain barrier and be metabolized in the brain. Fur-
ther, neurosteroids are produced de novo in the brain. Whether
of peripheral or central origin, all neuroactive steroids are derived
from cholesterol. The transport of cholesterol to the inner mito-
chondrial membrane, mediated by steroidogenic acute regula-
tory protein (StAR), is the rate-limiting step in steroidogenesis
(Stocco and Clark, 1996). At the inner mitochondrial mem-
brane, the enzyme P450 side-chain cleavage transforms cho-
lesterol to pregnenolone. Neuroactive steroids with activity at
GABAA receptors are metabolites of the precursor steroids deoxy-
corticosterone, progesterone, testosterone, and androstenedione
(Figure 1). Transformation of these precursors, respectively, ﬁrst
by 5α-reductase and then by 3α-hydroxysteroid dehydrogenase
(HSD) produces 3α,5α-THDOC, 3α,5α-P, and 5α-androstan-
3α-ol-17-one (3α,5α-A; androsterone). Each of these steroids,
in addition to the 5β-reduced pregnane steroid 3α-hydroxy-
5β-pregnan-20-one (3α,5β-P, pregnanolone), positively modu-
lates responses to GABA at GABAA receptors (Puia et al., 1990;
Park-Chung et al., 1999). Speciﬁcally, this means that the efﬁ-
cacy of GABA is increased by concentrations of steroid that do
not, by themselves, activate the receptor. In contrast, muscimol
and gaboxadol [4,5,6,7-tetrahydroisoxazolo (5,4-c)pyridin-3(-ol);
THIP] are direct agonists of GABAA receptors because they open
the Cl− channel in the absence of GABA. The pharmacological
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activity of neuroactive steroids depends on their isomeric con-
ﬁguration, which is determined by the steroidogenic enzymes
that are present. Transformation by 5β-reductase and then by
3β-HSD results in neuroactive steroids that have distinct phar-
macological activity resembling neuroactive steroids to which
a sulfate group has been added (Wang et al., 2002). Sulfation
by sulfotransferase enzymes is a low-energy strategy by which
the effects of neuroactive steroids on neurotransmission may be
adjusted (Gibbs et al., 2006). Sulfated or 3β-reduced steroids neg-
atively modulate GABAA receptors (e.g., pregnanolone sulfate,
epipregnanolone sulfate, androsterone sulfate, epiandrosterone
sulfate). Other activity includes negative modulation (e.g., allo-
pregnanolone sulfate, epipregnanolone sulfate) or positive mod-
ulation of NMDA receptor responses (e.g., epiallopregnanolone
sulfate). Thus, sulfation may rapidly and transiently enhance exci-
tatory neurotransmission, as suggested by Wu et al. (1991). The
effects of sulfated steroids on glutamate transmission are hypothe-
sized to regulate sensory processing andmemory (Valenzuela et al.,
2007). Overall, steroidogenesis allows formodulation of excitatory
and inhibitory neurotransmission related to endocrine activity
that may be an important regulator of sensitivity to environmental
stimuli and behavior.
In addition to modulating receptor responses, neurosteroids
have been shown to regulate neurotransmitter release. For exam-
ple, pregnenolone sulfate increased glutamate release in neonatal
cerebellar synapses (Zamudio-Bulcock and Valenzuela, 2011) and
cultured hippocampal neurons (Meyer et al., 2002). Likewise, an
increased probability of GABA release after application of preg-
nanolone was observed in studies using spinal motor neurons in
toad embryos (Reith and Sillar, 1997). Haage et al. (2002) reported
increased GABA release in isolated neurons from the medial pre-
optic area of rats after application of allopregnanolone. Thus,
neurosteroids can modulate excitatory and inhibitory synaptic
transmission by modulating receptor activity and neurotransmit-
ter release. However, the efﬁcacious actions of neuroactive steroids
at GABAA receptors are particularly powerful (Park-Chung et al.,
1999).
ETHANOL AFFECTS NEUROACTIVE STEROID AND
NEUROSTEROID CONCENTRATIONS
The ability of neuroactive steroids to modulate sensitivity to
ethanol via GABAA receptors has been reviewed recently (Morrow
et al., 2006; Biggio et al., 2007) and was the topic of a recent sym-
posium on the interactions between stress and ethanol (Morrow
et al., 2009). In addition to potentially sharing common receptor
mechanisms, a major idea explored in these publications was that
acute ethanol increases the release of neuroactive steroids. One
mechanism involves stimulation of the hypothalamic–pituitary–
adrenal (HPA) axis. Stimulation of the HPA axis results in the
release of adrenocorticotropic hormone (ACTH) from the pitu-
itary into circulation. ACTH can then stimulate the expression of
StAR protein and the mitochondrial enzyme CYP11A1 (P450scc)
through a second messenger pathway that involves cyclic adeno-
sine monophosphate. As a result, ACTH promotes the production
of pregnenolone fromcholesterol in the adrenal cortex (Lavoie and
King, 2009). As described, pregnenolone can be metabolized to all
other neuroactive steroids depending on which steroidal enzymes
are present (Figure 1). Also shown in Figure 1, hydroxysteroid
dehydrogenase is a key enzyme involved in the production of neu-
roactive steroids, and this enzyme requires nicotinamide adenine
dinucleotide phosphate (NADPH) or nicotinamide adenine din-
ucleotide (NADH) as a co-factor (Krause and Karavolas, 1980).
Because the metabolism of ethanol also requires this co-factor, one
possibility that requires additional investigation is that steroido-
genesis could be altered in the presence of high doses of ethanol
as the necessary co-factors are depleted (Crabb et al., 2004).
Several studies have shown that acute ethanol increases circu-
lating neuroactive steroids (e.g.,VanDoren et al., 2000; Porcu et al.,
2010).Asmentioned, ethanol appears to have this effect by increas-
ing pituitary release of ACTH in conjunction with vasopressin and
corticotropin releasing hormone (CRH; Lee et al., 2004). Adrena-
lectomy largely eliminates neuroactive steroids that are induced
by ethanol (Porcu et al., 2004), indicating that ACTH stimulates
adrenal production of neuroactive steroids. In rats, HPA axis acti-
vation and de novo synthesis of StAR protein are necessary for
a threshold dose of 1.5 g/kg ethanol to increase GABAergic neu-
roactive steroids in plasma and cerebral cortex (Boyd et al., 2010b).
Ethanol also stimulates de novo steroidogenesis within the brain in
principal excitatory neurons and glial cells (Chisari et al., 2010). In
hippocampal slices from 3-week-old rats, ethanol (50mM) stim-
ulated GABA release and increased the amplitude of postsynaptic
currents upon application, with a second amplitude increase 20–
30min after applicationof ethanol. Because the secondary increase
was blocked by an inhibitor of the enzyme 5α-reductase (ﬁnas-
teride), enzymatic conversion of neuroactive steroids appears to
have mediated this effect of ethanol (Sanna et al., 2004). These
data highlight the possibility of indirect effects of ethanol on
GABAergic neurotransmission via steroidogenesis, for which vari-
ability in these processes could account for individual differences
in sensitivity to ethanol.
Species differences in the efﬁcacy of ethanol to increase neu-
roactive steroid concentrations have been reported, but proce-
dural differences make comparison difﬁcult. For example, acute
ethanol increased plasma neuroactive steroids when given by
injection to rodents [mean blood-ethanol concentration (BEC),
212mg/dl] but did not change, or decreased neuroactive steroid
concentrations following intragastric administration in macaque
monkeys (mean BEC, 125mg/dl; Porcu et al., 2010). Another con-
found is interactions with innate biological rhythms, as some
neuroactive steroids have a diurnal rhythm, similar to corti-
sol (Weitzman et al., 1971). Porcu et al. (2008) demonstrated
that, in humans, deoxycorticosterone has a diurnal rhythm in
which concentrations are greater in the morning compared to
the evening. In contrast, concentrations of pregnenolone sulfate
were similar in the morning and evening, suggesting that diurnal
activity of speciﬁc steroidogenic enzymes could have contributed
to deoxycorticosterone concentrations. Whether ethanol affects
circulating neuroactive steroid concentrations could depend on
the time of day. In one study, young adult men that drank
0.80 g/kg ethanol at 6:00 pm had similar serum concentrations of
allopregnanolone (0.145 ng/ml) and pregnenolone (0.297 ng/ml)
compared to baseline (0.125 and 0.262 ng/ml, respectively; Porcu
et al., 2010). In contrast, Pierucci-Lagha et al. (2006) reported that
when young adult men drank the same dose of ethanol at 11:00
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FIGURE 1 | Neurosteroids modulating GABAergic neurotransmission are
produced by the precursor steroids deoxycorticosterone (3α,5α-THDOC,
allotetrahydrodeoxycorticosterone), progesterone (3α,5α-P, allopregna-
nolone; 3α,5β-P, pregnenolone; 3β,5α-P, epiallopregnanolone; 3β,5β-P,
epipregnanolone), and testosterone (3α,5α-A, androsterone; 3α,5β-A,
etiocholanolone) via the sequential actions of reductase and hydroxy-
steroid dehydrogenase enzymes. Ellipses highlight steroids known to
inﬂuence sensitivity to the behavioral or endocrine effects of ethanol. Alcohol
dehydrogenase and 3α-hydroxysteroid dehydrogenase require common
co-factors. Sulfotransferase enzymes adding a sulfate group rapidly alter the
pharmacological activity of neurosteroids. DHDOC, dihydrodeoxycortico-
sterone; HSD, hydroxysteroid dehydrogenase; NADPH, nicotinamide adenine
dinucleotide phosphate-oxidase; NADH, nicotinamide adenine dinucleotide;
scc, side-chain cleavage; StAR, steroidogenic acute regulatory protein.
am, plasma allopregnanolone (0.07 ng/ml) decreased and preg-
nenolone (4.56 ng/ml) increased compared to baseline (allopreg-
nanolone, 0.13 ng/ml; pregnenolone, 4.05 ng/ml). Further studies
of ethanol effects on circulating neuroactive steroids are needed
that include a range of BECs and times of day.
Possible species differences in ethanol sensitivity could relate
to basal levels of neuroactive steroids. For example, basal
pregnenolone was much greater in male cynomolgus mon-
keys (945 pg/ml) compared to humans (297 pg/ml), male rats
(165 pg/ml), or male mice (49 pg/ml), but 3α,5α-THP, 3α,5β-THP,
and 3α,5α-THDOC were much lower in cynomolgus monkeys
compared to rats, mice, and adult men (Porcu et al., 2010).
The relatively high basal pregnenolone concentration observed
in cynomolgus macaques suggests the potential for high concen-
trations of pregnenolone sulfate following sulfation that could
negatively modulate GABAA receptors (Park-Chung et al., 1999)
and potentiate NMDA responses to glutamate (Wu et al., 1991;
Park-Chung et al., 1997). High basal pregnenolone may predict
a lower potency of ethanol in behavioral assays. For example, 30
and 56mg/kg pregnenolone decreased responding for ethanol and
ethanol consumption in rats (Besheer et al., 2010). Although the
equivalent primate studies have not been conducted, and the levels
of neuroactive metabolites can make interpretation challenging, it
is possible that circulating levels of pregnenolone contribute to
individual and species differences in the effects of ethanol.
GABAA RECEPTOR-MEDIATED INHIBITORY SIGNALING
GABAA receptor-mediated inhibition can be roughly grouped into
two forms, “phasic” and “tonic” inhibition (Cavelier et al., 2005;
Farrant andNusser, 2005;Glykys andMody,2007a). Phasic inhibi-
tion refers to the long known, traditional inhibitory postsynaptic
currents (IPSCs), generated by GABAA receptors in the postsy-
naptic membrane that are transiently activated (hence the term
phasic) by vesicular release of GABA. The phasic nature of IPSCs
is due to the rapid removal of GABA from the synaptic cleft by dif-
fusion and uptake on plasma-membrane GABA transporters, as
well as desensitization of postsynaptic GABAA receptors. Con-
versely, tonic inhibition is a more recently discovered form of
steady state inhibitory current, generated primarily by extrasy-
naptically located GABAA receptors that are persistently activated
(hence the term tonic) by the ambient extracellular concentration
of GABA (Hamann et al., 2002; Cavelier et al., 2005; Farrant and
Nusser, 2005; Glykys and Mody, 2007a,b; Choi et al., 2008; Lee
et al., 2011). The extracellular concentration of GABA that dri-
ves tonic GABAA inhibition is determined by the balance between
GABA release (via vesicle exocytosis and various forms of non-
vesicular release) and GABA uptake by GABA transporters (Rossi
et al., 2003; Glykys and Mody, 2007b; Lee et al., 2010). Accordingly,
the magnitude of tonic GABAA inhibition is increased by blocking
GABA uptake, and decreased by blocking any of the various forms
of GABA release. Conversely, increasing GABA release increases
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the magnitude of tonic GABAA inhibition. Importantly, since a
main source of GABA release is the vesicular release that also gen-
erates phasic IPSCs, the magnitude of tonic GABAA inhibition
often varies in parallel with changes in IPSC frequency (Glykys
and Mody, 2007b).
The GABAA receptor is composed of ﬁve trans-membrane sub-
units arranged to form an anion-conducting pore, and themakeup
of subunits, from a family of 19 unique subunits (α1–6, β1–3, γ1–
3, δ, ε, θ,π, and ρ1–3), determines the sub-cellular location of the
receptor (synaptic versus extrasynaptic). The subunit composition
of GABAA receptors also determines their kinetic and pharmaco-
logical properties, including sensitivity to neurosteroids, ethanol,
and other GABAA modulatory compounds. Thus, interpreting the
behavioral impact and interactions of ethanol and neurosteroids
requires an understanding of the subunit properties, and their
distribution pattern in various brain regions.
One consistent and important GABAA receptor theme is that
δ subunits are located exclusively extrasynaptically, and it is such
δ subunit-containing, extrasynaptic GABAA receptors that medi-
ate tonic inhibition (Rossi and Hamann, 1998; Hamann et al.,
2002; Stell et al., 2003; Farrant and Nusser, 2005; Kelm et al.,
2008). The δ subunit is primarily expressed by a limited num-
ber of cell types in a few brain regions, including cerebellar and
hippocampal granule cells, thalamic relay neurons, and possibly
more restrictedly in subsets of cells elsewhere, including non-
granule hippocampal cells and some cortical cells (Wisden et al.,
1992). Thus, tonic inhibition is generally restricted to speciﬁc cell
types in particular brain regions. In these brain regions the δ
subunit generally pairs with α4 or α6 subunits, which together
endows the parent receptor with properties idealized for sens-
ing ambient GABA to generate tonic inhibition: a higher afﬁnity
for GABA and less receptor desensitization than other subtypes
of GABAA receptors (Saxena and Macdonald, 1994, 1996). How-
ever, although the δ subunit is solely expressed extrasynaptically
and typically co-assembles with α4 or α6 subunits, the latter sub-
units can also be part of functional, synaptic receptors that do
not contain δ subunits. Thus, while pharmacological or genetic
manipulations of the δ subunit can be unambiguously attributed
to effects on tonic GABAA inhibition,α4- or α6-speciﬁc manipula-
tions may affect synaptic transmission (i.e., IPSCs), extrasynaptic
transmission (i.e., tonic inhibition), or both. On the other hand,
the α6 subunit is expressed almost exclusively by cerebellar gran-
ule cells, making actions of α6-speciﬁc manipulations attributable
to actions at cerebellar granule cells. Other than the α5 subunit,
which is largely restricted to the hippocampus and cortex, the rest
of the GABAA subunits are more ubiquitously expressed mak-
ing attribution of subunit-speciﬁc manipulations to speciﬁc brain
region processing more complicated. Finally, although expression
of the δ subunit is restricted to only a few brain regions, because
of the constant nature of the tonic inhibition they generate, tonic
inhibition is signiﬁcantly more powerful than phasic inhibition,
mediating∼75% of total inhibition in cells that exhibit tonic inhi-
bition (Hamann et al., 2002). Thus, the δ subunit is potentially a
powerful target for neural modulation.
NEUROSTEROID ACTIONS AT GABAA RECEPTORS
As described in the introduction, at physiologically relevant con-
centrations, neurosteroids can either potently enhance GABAA
receptor function, or, in the case of sulfated neurosteroids, pow-
erfully suppress them. The diversity of neurosteroids combined
with their potency and respective abilities to enhance or suppress
GABAA receptor function enables a powerful ﬁne-tuning of the
GABAA system across behavioral states and across brain regions.
Early behavioral and electrophysiological studies suggested that
the δ subunit played a crucial role in mediating the actions of
neurosteroids, with many studies indicating that the δ subunit
imparted an increased sensitivity to neurosteroids (Mihalek et al.,
1999; Belelli et al., 2002; Wohlfarth et al., 2002; Stell et al., 2003),
although other studies suggested that the δ subunit decreased sen-
sitivity to neurosteroids (Zhu et al., 1996; Hamann et al., 2002).
However,more recent work on recombinant GABAA receptors has
determined that there is a conserved neurosteroid binding site on
α subunits (α1–5; Hosie et al., 2009). Thus, because all GABAA
receptors contain α subunits, neurosteroids are potent modula-
tors of most, if not all, known GABAA receptors, regardless of
subunit makeup. Such studies suggested that earlier data impli-
cating the δ subunit in neurosteroid sensitivity resulted from the
δ subunit increasing neurosteroid efﬁcacy rather than receptor
afﬁnity for neurosteroids. Thus, in principle, systemic neuros-
teroids could impact both phasic and tonic GABAA inhibition
throughout the brain, and selective actions on particular cell types
could be dependent on local synthesis. Nonetheless, in situ studies
showed that very low concentrations of exogenous neurosteroid
(<20 nM) powerfully enhanced tonic GABAA currents but not
phasic GABAA currents in the same preparation, and that knock-
ing out the δ subunit eliminated tonic GABAA current sensitivity
to neurosteroids (Stell et al., 2003). The contrast with data from
recombinant receptors suggests that in situ receptors may behave
differently, and that the δ subunit does affect receptor afﬁnity
in situ. In fact, studies examining GABAA currents in different
brain regions indicate that the sensitivity of both phasic and tonic
GABAA currents to neurosteroids varies across cell types, even
when apparently identical GABAA receptor subunits are involved
(Belelli et al., 2006). Such variability may be due to the phospho-
rylation state of the GABAA receptor and/or local neurosteroid
metabolism, two factors that add further control and complexity
to neurosteroid actions at GABAA receptors. Thus, although the
presence of the δ subunit or speciﬁc α, β, or γ subunit may impart
subtle differences to the parent receptor that are physiologically
relevant, it is unlikely that exogenous neurosteroids can be used as
subunit-selective modulators to identify crucial subunits or brain
regions involved in a particular behavioral response. Similarly, if
selective modulation of a speciﬁc GABAA subunit (such as genetic
deletion) has a signiﬁcant impact on a behavioral response to neu-
rosteroids, it should be interpreted with respect to the importance
of the brain region(s) in which the subunit is expressed to the
behavior, rather than to the particular sensitivity of the subunit to
neurosteroids.
ETHANOL ACTIONS AT GABAA RECEPTORS
Ethanol has also long been known to be a potent enhancer of
GABAA receptor-mediated inhibition, but identifying the mech-
anism(s) of action has been controversial, and is clearly even
more complex than for neurosteroid modulation. Several groups
have reported that concentrations of ethanol that are likely to be
achieved during moderate to abusive drinking (5–50mM) can
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enhance tonic GABAA inhibition via directly increasing the afﬁn-
ity of certain GABAA receptors for GABA, including α6βδ subunits
in cerebellar granule cells, α4βδ subunits in hippocampal granule
cells and thalamic relay neurons, and α1βδ subunits in hippocam-
pal interneurons (Wei et al., 2004; Hanchar et al., 2005; Glykys
et al., 2007). Most of the studies showing direct actions of ethanol
on GABAA receptors have observed this effect in receptors con-
taining the δ subunit, leading to the notion that the δ subunit
containingGABAA receptors are low-dose ethanol receptors (Han-
char et al., 2004; Olsen et al., 2007; Mody, 2008). Unfortunately,
demonstration of direct actions of ethanol on GABAA receptors
has been difﬁcult to replicate, and most researchers, using similar,
nearly identical techniques and preparations have been unable to
show any direct actions of ethanol on GABAA receptors of any
composition (Borghese et al., 2006; Borghese and Harris, 2007;
Botta et al., 2007a,b). Despite intensive efforts, the reasons for
this discrepancy have not yet been elucidated. One factor may
relate, at least in part, to the phosphorylation status of the GABAA
receptor, similar to neurosteroids. In particular, Choi et al. (2008)
determined that enhancement of tonic GABAA currents medi-
ated by GABAA receptors containing α4δ subunits required that
the receptor be phosphorylated by protein kinase (PK) Cδ, and
accordingly, knocking out PKCδ prevented ethanol from enhanc-
ing tonic GABAA currents in hippocampus and thalamus, and
reduced behavioral sensitivity to ethanol. While it is not clear
why the phosphorylation status of the GABAA receptor would be
so starkly different across laboratories, it does provide a poten-
tial mechanism explaining in part the discrepant observations
across laboratories regarding direct actions of ethanol on GABAA
receptor currents. Intriguingly, although PKCδ expression corre-
lates with the GABAA δ subunit expression in hippocampus and
thalamus, it is not expressed in the cerebellar granule cell layer,
where α6δ subunits are expressed. This raises the possibility that
if phosphorylation status explains the discrepant observations of
ethanol-induced potentiation of tonic GABAA currents in cerebel-
lar granule cells, there must be kinases other than PKCδ to serve
that role in the cerebellar granule cell layer.
In addition to the potential direct action of ethanol on some
GABAA receptors, it is widely accepted that ethanol strongly
enhances vesicular release of GABA. As a result, the frequency of
IPSCs increases and, in cells that express extrasynaptic GABAA
receptors, the magnitude of tonic GABAA currents is strongly
enhanced due to the accumulation of vesicular release of GABA in
the extrasynaptic space. Thismechanism is observed inmanybrain
regions, including the cerebellum, ventral tegmental area, substan-
tia nigra, and amygdala, but lacking in others, including cortex,
lateral septum, and thalamus (Kelm et al., 2011). The mecha-
nisms underlying ethanol-induced vesicular GABA release are not
fully understood, but often appears to involve G-protein coupled
receptor systems (Kelm et al., 2011). Thus, regardless of whether
ethanol acts directly on GABAA receptors, ethanol can increase
both the frequency of IPSCs as well as the magnitude of the tonic
GABAA current. Therefore, even if ethanol does not directly affect
δ subunits in a particular brain region or under particular condi-
tions, knocking out (or selectively modifying) the δ subunit could
still strongly inﬂuence the response to ethanol, because the lack
of extrasynaptic GABAA receptors will eliminate tonic GABAA
currents that would normally be generated by increased vesicular
release of GABA.
INTERACTIONS BETWEEN NEUROSTEROIDS AND ETHANOL
AT GABAA RECEPTORS
Given that neurosteroids and ethanol converge on GABAA recep-
tors, it is worth considering how they may interact with each other
at the GABAA receptor. Given the more consistent and ubiquitous
direct actions of neurosteroids on GABAA receptors compared to
ethanol, it seems unlikely that the two compounds share a binding
site, and thus will not compete or interact directly. It is, how-
ever, possible that for those GABAA receptors that are directly
modulated by both neurosteroids and ethanol (see above), com-
bined exposure will have a synergistic or other interactive impact.
However, to our knowledge there are no reports of such interac-
tions, and given current controversies about direct actions for both
ethanol and neuroactive steroids, it may be difﬁcult to ascertain
such interactions at the receptor level. Perhaps the most obvious
way in which neurosteroids and ethanol are likely to interact at the
GABAA receptor is via ethanol-induced increase in vesicularGABA
release as described above. It is clear that neurosteroid effects on
GABAA receptors are relatively ubiquitous across receptors with
different subunit compositions. Therefore, it is likely that neuros-
teroids will be active at GABAA receptors in brain regions in which
ethanol increases GABA release. Indeed, there is overlap between
the documented actions of neurosteroids at GABAA receptors and
documented ethanol-induced vesicular GABA release in the cere-
bellum, hippocampus, thalamus, and amygdala (Hamann et al.,
2002; Stell et al., 2003; Carta et al., 2004; Belelli et al., 2006;
Criswell et al., 2008; Kelm et al., 2008, 2011). Accordingly, in those
brain regions, since neurosteroids enhance the actions of GABA
at GABAA receptors and ethanol enhances GABA release, there
will likely be a synergistic interaction if cells in those brain regions
are exposed to both simultaneously. Importantly, since ethanol
increases neurosteroid release both systemically and locally (see
earlier sections), such a synergistic enhancement of GABAA cur-
rents is likely. Irrespective of the cellular/molecular mechanisms
at play, since both neurosteroids and ethanol enhance GABAA
currents, it is likely that they may substitute for each other behav-
iorally.Whereas both tonic and phasic inhibition may decrease the
magnitude and duration of excitatory input, because tonic inhibi-
tion is persistent and distributed, it may increase the threshold of
depolarization required for a cell to ﬁre (Farrant and Kaila, 2007,
p. 70). This leads to the hypothesis that neurosteroids and ethanol
could modulate the threshold for stimulation by sensory input by
enhancing tonic inhibition in brain areas containing δ subunits,
whereas the activity of neurosteroids and ethanol in other brain
areas could affect the magnitude of physiological or behavioral
response to a stimulus.
COMMON RECEPTOR ACTIVITY OF ETHANOL AND
NEUROACTIVE STEROIDS: EVIDENCE FROM BEHAVIORAL
PHARMACOLOGY
Changes in sensory thresholds are a major aspect of sleep, which
involves modulation of thalamocortical excitability (Huguenard
and McCormick, 2007). Ethanol (50mM) has been shown to
suppress the activity of thalamocortical relay neurons (Jia et al.,
www.frontiersin.org January 2012 | Volume 3 | Article 10 | 5
Helms et al. Neurosteroid effects on sensitivity to ethanol
2008), and as described above, these contain δ subunits. How-
ever, few studies have examined the interactive effects of ethanol
and neuroactive steroids on psychophysical parameters and these
have mainly been restricted to response magnitude or latency,
rather than response threshold. Nonetheless, the idea that the
effects of ethanol on sensorimotor processing are inﬂuenced by
neuroactive steroids is not well-supported by the limited data
available. For example, a very high dose of ethanol (5.25 g/kg,
i.g.) administered to rats on post-natal days 4–9 did not alter
the magnitude of startle to a 110-db noise, or the attenuation
of this startle by a preceding 60-db tone (i.e., prepulse inhibition)
compared to vehicle controls when the animals were tested as ado-
lescents or adults (70 days of age; Woolfrey et al., 2005). A single
study of neuroactive steroids in healthy women found that nei-
ther startle magnitude nor prepulse inhibition were affected by
allopregnanolone (0.05mg/kg; Kask et al., 2009). In contrast, the
magnitude of prepulse inhibition was increased in adult rats by
administration of allopregnanolone (but not pregnenolone sul-
fate) to hippocampal CA1 (Darbra et al., 2011), but decreased by
systemic administration of allopregnanolone (10mg/kg) during
post-natal days 5–9 (Darbra and Pallarès, 2010). Thus, adminis-
tration of allopregnanolone (Darbra and Pallarès, 2010) but not
ethanol (Woolfrey et al., 2005) to neonates decreased prepulse
inhibition in adulthood, at least at the doses tested. Because none
of these studies examined the interaction between ethanol and
neuroactive steroids, it is unknown whether neuroactive steroids
could have a modulatory role under conditions in which ethanol
decreased arousal and stimulus processing.
Another set of studies measured cortical electrical responses
after presentation of auditory stimuli (event-related potentials,
ERPs). Allopregnanolone and ethanol decreased the amplitude
of ERPs in the cortex and amygdala, consistent with decreased
stimulus efﬁcacy (Slawecki et al., 2000). The same study found
that the combination of sub-threshold doses of allopregnanolone
(5.0mg/kg) and ethanol (0.50 g/kg) decreased peak amplitudes
in the amygdala, indicative of decreased arousal, but no additive
effects were observed in the cortex. Ethanol vapor inhalation for
14 h/day for 5weeks did not affect ERPs, but tolerance developed
to the decrease in ERPs produced by allopregnanolone (Slawecki
et al., 2005), suggesting that chronic ethanol exposure caused
molecular adaptations of GABAA receptors (e.g., subunit compo-
sition) resulting in altered neurosteroid pharmacology/sensitivity
(Liang et al., 2009). To our knowledge, there are no studies of
ERPs in humans evaluating the interaction between neuroactive
steroids and ethanol. Overall, these limited data suggest that the
additive effects of ethanol andneuroactive steroids onneural activ-
ity depend on the brain region examined, which could be due to
the localization of ethanol-induced GABA release, or to the pres-
ence or absence of speciﬁc GABAA receptor subunits, including
those that mediate tonic inhibition.
A much more extensive body of behavioral data that addresses
common receptor activity of ethanol and neuroactive steroids
includes consummatory behaviors and discriminative stimulus
effects. Neurons within the circuitry mediating contextual, rein-
forcing, or other stimulus properties of ethanol are likely to
regulate ethanol consumption. The threshold at which ethanol-
associated stimuli affect neurotransmission could be modulated
by neurosteroids, thus providing a mechanism by which neuroac-
tive steroids regulate ethanol intake.With regard to consummatory
behavior, compared to vehicle administration, mice administered
the direct GABAA agonist gaboxadol [4,5,6,7-tetrahydroisoxazolo
(5,4-c)pyridin-3(-ol); THIP] at a dose (8mg/kg) presumably
selective for δ-containing GABAA receptors, showed a selective
decrease in ethanol (not water) intake, and a lower latency to
drink either solution (Ramaker et al., 2011). These data impli-
cate extrasynaptic GABAA receptors in regulating consummatory
behavior generally (Kelley et al., 2005), and further suggest that
tonic GABAA inhibition can selectively regulate ethanol intake.
Thus, the ability of neuroactive steroids to modulate tonic inhi-
bition could make them therapeutically useful for alcohol abuse.
Consistent with this possibility, neuroactive steroids are associ-
ated with the conditioned aspects of consummatory behavior. For
example, anticipation and consumption of food increased plasma
and cerebrocortical allopregnanolone and THDOC (Pisu et al.,
2006). Because Ramaker et al. (2011) did not measure response
thresholds with gaboxadol, nor was there a measure of condi-
tioned stimulus effects that could regulate drinking, the behavioral
processes affected by gaboxadol that underlie the decrease in
ethanol intake are not clear. Gaboxadol-induced tonic currents
in cerebellar granule cells (α6δ; Meera et al., 2011) and thalamic
neurons (Herd et al., 2009) are greatly reduced in δ knockout mice,
indicating that this subunit is important for sensitivity to gabox-
adol. Another study suggested that δ subunits in the striatum
are involved in ethanol drinking. Nie et al. (2011) used viral-
mediated RNA interference to decrease GABAA receptor δ subunit
mRNA and protein approximately two-fold in the medial nucleus
accumbens shell. Eighteen days after infusion, ethanol but not
sucrose intake under intermittent access decreased from an aver-
age of 4.5 g/kg/day to 2.5 g/kg/day. Suppression of δ subunits in
the medial shell was suggested to decrease ethanol-induced poten-
tiation of tonic inhibition in a brain area that mediates ethanol
reinforcement. By extension, variation in δ subunit expression in
the medial shell and perhaps potentiation of tonic inhibition by
neurosteroids could bemechanisms for variation of ethanol effects
within and across individuals.
By far, the greatest amount of data addressing the role of neu-
roactive steroids in sensitivity to ethanol has been obtained using
drug discrimination procedures. In these procedures, a speciﬁc
response is reinforced (e.g., pressing the one of two levers results
in food presentation) following administration of a given dose
of a drug such as ethanol, and another response (e.g., pressing
the other lever) is reinforced following administration of vehi-
cle. The animal’s perception of the effect of the drug is the only
cue guiding its choice of which response to perform. Once the
animals reliably respond on the drug-associated lever after train-
ing drug administration, test drugs can be administered. A test
drug may be shown to substitute for the training drug, i.e., pro-
duce responding on the lever associated with the training drug,
indicating similar discriminative stimulus effects. Threshold and
magnitude of response can be dissociated in drug discrimination
data by potency (effective dose, ED50) and efﬁcacy (maximum
responding on the ethanol lever), respectively. Discrimination of
the stimulus effects of drugs can be trained in humans using the
same operant techniques. Drugs that positively modulate GABAA
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receptors, including ethanol, and produce similar discriminative
stimulus effects also tend to produce common subjective effects in
humans (Kelly et al., 2003).
Studies in non-human primates indicate that the discrimina-
tive stimulus effects of a wide range of ethanol doses (1.0–2.0 g/kg)
are mediated largely by GABAA receptors (Grant et al., 2000;
Vivian et al., 2002; Helms et al., 2009). In contrast, the discrimina-
tive stimulus effects of higher doses of ethanol (2.0 g/kg) appear
to involve speciﬁc subtypes of GABAA receptors (i.e., zolpidem-
sensitive α1-containing; Helms et al., 2008). The discriminative
stimulus effects of 5mg/kgpregnanolone are alsomediatedbypos-
itive modulation of GABAA receptors. For example, in rats trained
to discriminate pregnanolone, high levels of responding on the
pregnanolone-appropriate lever occurred after administration of
benzodiazepines and barbiturates, which are positive modulators
of GABAA receptors. In contrast, the direct agonists muscimol
and gaboxadol produced low levels of pregnanolone-appropriate
responding (Engel et al., 2001). Thus, the discriminative stimulus
effects produced by GABAA receptor agonists and positive mod-
ulators are distinct. Consistent with this conclusion, in animals
trained to discriminate ethanol, the direct agonists muscimol and
gaboxadol do not produce ethanol-like effects (cynomolgus mon-
keys, Grant et al., 2000; mice, Shelton and Grant, 2002). The activ-
ity of gaboxadol as an agonist rather than a positivemodulatormay
account for its lack of ethanol-like stimulus effects. On the other
hand, if infused directly into the nucleus accumbens or amygdala,
muscimol can substitute for the discriminative stimulus effects of
peripherally administered ethanol in rats (Hodge and Cox, 1998).
Taken together, these data suggest that, although neurosteroids
can directly activate GABA currents at high concentrations (Hosie
et al., 2006), ethanol-like discriminative stimulus effects occur at
lower, positive-modulatory concentrations. Second, interactions
among speciﬁc brain regions may contribute to the discriminative
stimulus effects of ethanol. For example,Hodge et al. (2001) found
that allopregnanolone substituted for the discriminative stimulus
effects of systemic ethanol when administered into the nucleus
accumbens but not the hippocampus (CA1). Thus, hippocam-
pal CA1 neurons that are sensitive to neurosteroids may not be
involved in ethanol-like discriminative stimulus effects.
The GABAA receptor subtypes at which neuroactive steroids
produce discriminative stimulus effects similar to ethanol have
not been extensively investigated. In one study, δ subunit knock-
out mice learned to discriminate 1.5 g/kg ethanol, and showed
similar substitution of neuroactive steroids (pregnanolone and
alphaxalone) for the discriminative stimulus effects of ethanol
(Shannon et al., 2004). Thus, δ subunits do not appear to be
necessary for the ethanol-like discriminative stimulus effects of
neuroactive steroids. Zolpidem is an imidazopyridine with selec-
tivity for α1-containing GABAA receptors (Lüddens et al., 1994),
which combine with γ subunits and are purported to be primarily
synaptic, although co-assembly with δ subunits and mediation of
tonic currents has been observed in interneurons of the hippocam-
pus (Glykys et al., 2007). Predominantly, however, α1-containing
receptors are synaptic and therefore mediate phasic GABA neuro-
transmission. In drug discrimination procedures, zolpidem sub-
stituted for the discriminative stimulus effects of pregnanolone in
rats (Engel et al., 2001) but not mice (Shannon et al., 2005a,b),
and no data exist for primates. Zolpidem partially substituted
for ethanol in rats (Sanger et al., 1999) but not mice (Shannon
et al., 2004) and completely substituted for 2.0 g/kg ethanol in
cynomolgus monkeys (Helms et al., 2008). Overall, these data sug-
gest that α1 subunits could mediate the discriminative stimulus
effects of both ethanol and neuroactive steroids under some con-
ditions. However, whether this subunit is involved in the ethanol-
like effects of neuroactive steroids has not been studied. Finally,
using the 5α-reductase inhibitor ﬁnasteride, the subjective effects
of ethanol (0.7–0.8 g/kg, BEC, 50–70mg/dl) were attenuated in
humans, but only in individuals homozygous for the A (but not
the G) allele at the GABAA receptor α2 subunit gene (Pierucci-
Lagha et al., 2005). These data suggest that the subjective effects
of ethanol are enhanced by neuroactive steroids in a select popu-
lation carrying a polymorphism in the α2 subunit of the GABAA
receptor. The role of α2 subunits in the discriminative stimulus
effects of ethanol and neuroactive steroids has not been explored
due to a lack of drugs with appropriate selectivity.
The GABAA receptors mediating the ethanol-like effects of
neuroactive steroids have been studied using pharmacological
antagonism. Ro15-4513 is a partial inverse agonist with high afﬁn-
ity for receptors containingα4,α5, orα6 subunits and lower afﬁnity
for α1, α2, or α3 subunits. This drug is celebrated as a competi-
tive antagonist of the electrophysiological and behavioral effects
of ethanol (Suzdak et al., 1986; Wallner and Olsen, 2008). In
drug discrimination studies, we found that Ro15-4513 antago-
nized the substitution of allopregnanolone and pregnanolone for
the discriminative stimulus effects of ethanol (Figure 2). Antag-
onism of pregnanolone substitution for ethanol was observed
in 6/6 monkeys trained to discriminate 1.0 g/kg ethanol, and
in 3/5 monkeys trained to discriminate 2.0 g/kg ethanol. Ro15-
4513 antagonized allopregnanolone substitution for ethanol in
3/6 monkeys trained to discriminate 1.0 g/kg ethanol, and 4/5
monkeys trained to discriminate 2.0 g/kg ethanol. Among the
monkeys showing antagonism, Ro15-4513 resulted in decreased
potency, but not efﬁcacy, of these neuroactive steroids to sub-
stitute for ethanol. In addition, according to an apparent pA2
analysis (Rowlett and Woolverton, 1996), the estimated afﬁnity
of Ro15-4513 for the receptor population mediating substitution
of pregnanolone (pKB of 5.2–7.0) and allopregnanolone (pKB of
6.1–8.9) overlapped with zolpidem (pKB of 6.3–8.0). These afﬁn-
ity estimates suggest that pregnanolone and allopregnanolone act
at benzodiazepine-sensitive and -insensitive GABAA receptors to
produce discriminative stimulus effects similar to ethanol. Because
the γ subunit is obligatory for benzodiazepine sensitivity and this
subunit is primarily synaptic (Möhler, 2006), these data suggest
that the ethanol-like discriminative stimulus effects of neuroac-
tive steroids aremediated by synaptically locatedGABAA receptors
that regulate phasic inhibition.
In contrast to the ethanol-like effects of positive modulators of
GABAA receptors, neuroactive steroids that negatively modulate
GABAA receptors, including epipregnanolone and epiallopreg-
nanolone sulfate, might antagonize the discriminative stimulus
effects of ethanol. Our preliminary data indicate that epipreg-
nanolone (0, 10, 17, 30mg/kg, s.c.) and epiallopregnanolone (0,
17, 30mg/kg, s.c.) administered 30min prior to ethanol (0.25–
2.5 g/kg, i.g.) blocked (≤20% ethanol-appropriate) discriminative
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FIGURE 2 | Among male (n=6) and female (n=6) cynomolgus
macaques that were trained to discriminate 1.0 or 2.0 g/kg
ethanol, pregnanolone produced ethanol-like discriminative
stimulus effects in all monkeys, which were antagonized when
Ro15-4513 (symbols indicate doses in mg/kg, i.m.) was
administered after pregnanolone, 5min before the levers
extended into the chamber. Shifts in the dose-response curves of
four monkeys are shown.
effects in only a subset of cynomolgus monkeys. Speciﬁcally,
epipregnanolone blocked the discriminative stimulus effects of
ethanol in 1/6 of monkeys trained to discriminate 1.0 g/kg ethanol,
and in 2/6 monkeys trained to discriminate 2.0 g/kg ethanol. In
another study in rats, administration of epipregnanolone (10–
20mg/kg, i.p.) decreased responses for ethanol measured over
30min from 40 to 20 (O’Dell et al., 2005). Although preliminary,
these data suggest that neuroactive steroid negative modulators
could block the subjective effects of ethanol and consequently
responding for ethanol, and thus could be therapeutic targets.
However, these data are also consistent with the wide individ-
ual differences in the substitution patterns of neuroactive steroids
(e.g., Bowen et al., 1999; Grant et al., 2008a), the causes of which
are currently unknown. Some possible sources of individual dif-
ferences in the modulation of ethanol effects by neuroactive
steroids could be basal hormone concentration,polymorphisms in
GABAA receptor subunits, basal activity of steroidogenic enzymes,
reproductive state, or the effects of stress on HPA axis function.
Many studies have indicated that physiological concentrations
of the neuroactive steroids allopregnanolone and pregnanolone
substitute for the discriminative stimulus effects of ethanol (Grant
et al., 1996, 1997, 2008a; Bowen et al., 1999). These ﬁndings
suggest that endogenous variation in neuroactive steroids could
inﬂuence sensitivity to ethanol. Indeed, the potency of 1.0 g/kg
ethanol (Grant et al., 1997) but not 2.0 g/kg ethanol (Green et al.,
1999) to produce discriminative stimulus effects was greater dur-
ing the luteal compared to the follicular phase of the menstrual
cycle in monkeys. During the luteal phase, peak progesterone con-
centration is associated with greater circulating concentrations
of progesterone-derived neuroactive steroids, including allopreg-
nanolone and pregnanolone (Genazzani et al., 1998; Hill et al.,
2005). Although self-reported subjective effects of low ethanol
doses (up to 0.6 g/kg) did not vary across a menstrual cycle in
women (Holdstock and de Wit, 2000), sensitivity to the benzodi-
azepine triazolam was greater during women’s luteal compared to
the follicular phase when measured using a drug discrimination
procedure (Kelly et al., 2001). Despite the absence of menstrual
cycles in males, male and female cynomolgus monkeys show
only minor differences in the ethanol-like discriminative stimulus
effects of neuroactive steroids. For example, the potency of andros-
terone to produce ethanol-like stimulus effects is on average lower
in males compared to females (Grant et al., 2008b). In humans,
subjective effects associated with varying plasma concentrations
of neuroactive steroids could contribute to regulation of ethanol
consumption. For example, change in plasma neuroactive steroid
concentration after consuming 0.80 g/kg ethanol (11:00 am) cor-
related signiﬁcantly with subjective effects of ethanol including
“liking” (pregnenolone, r = 0.53; allopregnanolone, r = 0.50) and
“want more alcohol” (r = 0.51; Pierucci-Lagha et al., 2006). These
data further suggest that neuroactive steroids produced as a result
of ethanol self-administration could subsequently regulate intake.
By extension, the effects of ethanol may vary with other endoge-
nous (e.g., stress: Droogleever Fortuyn et al., 2004) or disease
states (e.g., premenstrual dysphoric disorder, Bäckström et al.,
2011) associated with altered concentration of, or sensitivity to,
GABAergic neuroactive steroids. Such endogenous conditions
could inﬂuence the risk of alcohol abuse.
THE ROLE OF NEUROACTIVE STEROIDS IN CHRONIC
ETHANOL EFFECTS AND ETHANOL WITHDRAWAL
Although naïve individuals differ in sensitivity to the acute effects
of ethanol, a much greater variability in sensitivity to ethanol
occurs within individuals as a result of repeated administra-
tion. Neuroadaptation to chronic ethanol involves decreased
sensitivity to GABA and changes in GABAA receptor subunit
expression and function. These neuroadaptations have additional
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pharmacological consequences including decreased sensitivity to
benzodiazepines and increased sensitivity to some neuroactive
steroids (reviewed by Biggio et al., 2007). Changes in subunit
expression after ethanol or progesteronewithdrawal differ between
brain areas (cerebral cortex, cerebellum, and hippocampus are
most often studied), but a relatively consistent result is decreased
expression of α1 and δ subunits and increased expression of α4
and α6 subunits (Mhatre and Ticku, 1992; Rani and Ticku, 2006).
Electrophysiological studies in cultured neurons have conﬁrmed
that the changes in GABAA receptor subunits after chronic ethanol
treatment and withdrawal are associated with changes in receptor
function (reviewed by Kumar et al., 2009). In a report by Shen et al.
(2011), endocytosis of GABAA receptors containing α4 and δ sub-
units was shown to be increased by ethanol treatment in cultured
hippocampal neurons. In another model, rats are administered
high doses of ethanol intermittently (chronic intermittent ethanol,
CIE: 5 g/kg every other day for 5 days, then 6 g/kg/day for 55 days)
and then brain slices are prepared for electrophysiology. The CIE
treatment results in the decreased efﬁcacy of several GABAer-
gic sedative/hypnotic drugs (e.g., ethanol, zolpidem, gaboxadol)
to potentiate tonic currents in hippocampal slices (Liang et al.,
2004, 2009). At the same time, these drugs showed greater efﬁ-
cacy to potentiate phasic (synaptic) currents after CIE. This result
was related to decreased α1 subunits at synaptic sites, decreased
α4, β, and δ subunit protein at extrasynaptic sites, and increased
α4, β, and γ2 subunits at synaptic sites (Liang et al., 2004, 2009).
Notably, similar to the effects of withdrawal from chronic ethanol,
increased α4 subunit expression is observed in the hippocam-
pus after chronic allopregnanolone and withdrawal (reviewed by
Smith et al., 2007). Overall, these data suggest that the neuroad-
aptations to chronic ethanol and neuroactive steroids are similar,
possibly to maintain homeostasis of inhibitory neurotransmis-
sion. Regardless of the mechanisms by which it is accomplished,
i.e., direct receptor action by neuroactive steroids or increased
GABA release by ethanol,positivemodulation of GABAA receptors
appears to be a common effect of ethanol and exogenous neuroac-
tive steroids that can result in homeostatic molecular adaptations
to restore GABAergic tone. Such homeostatic adaptations result
in withdrawal following the removal of neurosteroids or ethanol.
The great complexity of results from in vitro studies, in which
differences are commonly found between brain areas, suggests that
in vivo pharmacological studies could inform changes in GABAA
receptor function after chronic ethanol andwithdrawal. For exam-
ple, 10mg/kg alphaxalone induced sleep, as measured by a loss of
righting reﬂex. After CIE, however, the duration of sleep induced
by alphaxalone was decreased, indicating cross-tolerance (Cagetti
et al., 2003). In contrast, the efﬁcacy of alphaxalone to increase
time spent on the open arms in the elevated plus maze (purport-
edly an anxiolytic effect) was increased after CIE (Cagetti et al.,
2004). In the same study, rats exposed to CIE were sensitized to
the convulsant effect of pentylenetetrazol, as 20–25mg/kg induced
seizures in this group compared to 40mg/kg in control rats. This
treatment also resulted in greater sensitivity to the anticonvulsant
effects of alphaxalone. Likewise, the anticonvulsant efﬁcacy and
potency of allopregnanolone (Devaud et al., 1995) and THDOC
(Devaud et al., 1996) was increased by chronic ethanol treatment
in rats (liquid diet, 10–12 g/kg/day for 14 days) and mice (72 h
ethanol vapor inhalation, Finn et al., 2000). These data indicate
that chronic ethanol and withdrawal are associated with increased
sensitivity, rather than cross-tolerance, to the anticonvulsant and
possibly the anxiolytic effects of GABAergic neuroactive steroids.
Thus, data from the limited studies conducted so far suggest that
adaptations to chronic ethanol and withdrawal alter the effects of
neuroactive steroids in a behavior-speciﬁc manner likely related
to the GABAA receptor subunits expressed in the brain regions
mediating the behavior that is being studied.
NEUROACTIVE STEROID REGULATION OF THE HPA AXIS AND
INTERACTIONS WITH ETHANOL
Similar to the negative feedback of the HPA axis by glucocorti-
coids, GABA is a primary regulator of hypothalamic responses
to stress. Activity of the HPA axis, beginning with secretion of
CRH, is inhibited by GABA (Calogero et al., 1988). Decreased
GABAergic activity during acute stress (Biggio et al., 1990) results
in stimulation of the HPA axis and increased brain and plasma
concentrations of neuroactive steroids, at least in rodents (Purdy
et al., 1991). A variety of stressors have been shown to increase
plasma and/or brain neuroactive steroids to concentrations that
modulate GABAA receptors in vitro (Belelli et al., 2002). For exam-
ple, swim stress (22˚C, 10min) in rats increased allopregnanolone
in plasma (<1 ng/ml to 2.5 ng/ml after 70min) and brain (cerebral
cortex, 2.5 ng/ml to 5 ng/ml after 10min; hypothalamus,<2 ng/ml
to 4.5 ng/ml after 40min;Purdy et al., 1991). Similarly,plasma allo-
pregnanolone increased from 1.0 to 1.2 nmol/l during oral defense
for a Ph.D. degree (Droogleever Fortuyn et al., 2004). Increased
neuroactive steroids are proposed to dampen the physiological
impact of the stress and mediate restoration of homeostasis of the
HPA axis (Finn and Purdy, 2007). For example, allopregnanolone
decreased anxiety in response to heat stress and administration of
CRH (Patchev et al., 1994, 1996). A recent report indicated that
physiological concentrations of allopregnanolone, THDOC, and
pregnenolone in cell culture inhibited CRH reporter gene activity
and forskolin-stimulated transcription (Budziszewska et al., 2010).
Overall, these data are consistent with the idea that endogenous
GABAergic neuroactive steroids exert negative feedback on stress
responses. Chronic stress has been proposed to result in adapta-
tions of the HPA axis that increase risk for alcohol abuse (Lovallo
et al., 2000; Biggio et al., 2007). Neuroactive steroids may be a
target for amelioration of HPA axis abnormalities.
The interaction between neuroactive steroids, ethanol, and
chronic stress has been extensively investigated using the social iso-
lation model in which rodents are housed individually after wean-
ing. Compared to group-housed rats, socially isolated rats had
lower cortical and plasma concentrations of pregnenolone, prog-
esterone, THDOC and allopregnanolone, and 32% greater basal
concentration of plasma corticosterone (Serra et al., 2000). After
acute ethanol (1.0 g/kg), however, socially isolated rats had greater
concentrations of plasma and cerebral cortex pregnenolone, prog-
esterone, allopregnanolone, and THDOC compared to group-
housed rats (Serra et al., 2003). The chronic stress of social
isolation therefore down-regulated the basal concentration of neu-
rosteroids, perhaps lowering inhibitory control of the HPA axis,
resulting in greater corticosterone. Furthermore, the efﬁcacy of
ethanol to increase neuroactive steroids was greater following
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social isolation, perhaps related to suppressed basal concentra-
tions. In contrast, following treatment with chronic ethanol (8–
10 g/kg/day for 7 days), the efﬁcacy of ethanol to increase plasma
concentrations of neuroactive steroidswas lower compared to con-
trol diet (Boyd et al., 2010a). Insofar as stress substitutes for, and
has additive effects toward, social anxiety induced by ethanol with-
drawal (5 days ethanol diet, restraint stress; Breese et al., 2004), one
hypothesis is that ethanol withdrawal may have effects similar to
stress, and potentiate the increase in neuroactive steroid concen-
tration after acute ethanol. To our knowledge, the effects of ethanol
withdrawal on the efﬁcacy of acute ethanol to alter concentrations
of neuroactive steroids have not been studied.
Sanna et al. (2011) hypothesized that, in socially isolated mice,
ethanol drinking would normalize neurosteroid concentrations.
Data supporting this hypothesis would suggest that increased neu-
roactive steroids resulting from consumption of ethanol might
contribute to reinforcement of ethanol drinking. This hypoth-
esis was previously investigated by Janak et al. (1998), showing
that 3mg/kg allopregnanolone slightly increased ethanol self-
administration from 0.30 to 0.43 g/kg/30min session. However,
Sanna et al. (2011) reported that hippocampal allopregnanolone
concentration did not differ between mice consuming ethanol
(group-housed, 3.5 g/kg/2 h session; socially isolated, 4.25 g/kg/2 h
session) or water for 6weeks, and remained lower in socially iso-
lated (11–13 ng/g) compared to group-housed mice (15–17 ng/g).
Thus, ethanol consumption did not normalize hippocampal
(Sanna et al., 2011) or cerebral cortical (rats, Pisu et al., 2011)
neurosteroids that were suppressed by the chronic stress of social
isolation. However, there may be differences between voluntary
and experimenter-administered ethanol. The proceedings of the
2008Volterra symposium (Morrow et al., 2009) reported that Big-
gio’s lab observed a two-fold increase in cortical allopregnanolone
in socially isolated rats exposed to intermittent ethanol vapor
for 8 days (BEC, 205mg/dl at sacriﬁce; 91% increase in group-
housed rats). It may be that compensatory processes induced by
ethanol-conditioned stimuli during voluntary drinking maintain
neurosteroid homeostasis, similar to neurosteroid regulation by
the anticipation of food (Pisu et al., 2006).
Changes in the expression of GABAA receptor subunits during
chronic stress or ethanol appear to alterGABAA receptor-mediated
tonic currents. As a result, changes in the ability of neuroactive
steroids to modulate tonic currents might inﬂuence the threshold
for HPA axis stimulation. In support of this idea, socially isolated
rats showed greater expression of α4 and δ subunits in the hip-
pocampus compared to group-housed rats (Serra et al., 2006),
and greater enhancement of tonic current by gaboxadol (Sanna
et al., 2011). Furthermore, δ subunit mRNA expression and pro-
tein was attenuated by ethanol consumption in socially isolated
mice, in which basal expression was 50% greater than group-
housed mice (Sanna et al., 2011). Whereas social isolation resulted
in approximately 10% greater α4 subunit protein compared to
group-housed mice drinking water, this difference was absent
when the mice drank ethanol, suggesting that ethanol consump-
tion opposed the effects of stress on α4 subunit expression and
peptide up-regulation (Sanna et al., 2011). Ethanol consumption
in socially isolatedmice also resulted in electrophysiological effects
of gaboxadol more similar to group-housed mice, consistent with
regulation of α4δ subunits. Additional research is needed, as the
combination of chronic ethanol and associated social stress in
humans could have unique pharmacological consequences that
are signiﬁcant for the treatment of alcoholism.
Changes in GABAA receptor subunit expression in relation to
ethanol consumption have been studied using a primatemodel. By
using non-human primates, chronic alcohol intake can be charac-
terized in the absence of confounding variables present in human
post-mortem studies (e.g., reliable measures of intake, multi-drug
histories, nutrition). Studies using monkeys model important
aspects of human alcohol consumption, including alcoholic-like
patterns of intake with high (>100mg/dl) BECs (Grant et al.,
2008b).Aftermore than 18months of ethanol self-administration,
previous studies found marked alterations in GABAA and NMDA
receptor subunit mRNA expression in the dorsal lateral prefrontal
cortex (DLPFC) and the orbital frontal (OFC) but not in anterior
cingulate cortex (ACC; Hemby et al., 2006; Acosta et al., 2010).
Speciﬁcally, the GABAA receptor subunits α2, α4, β1, β3, γ1, γ2,
γ3, were decreased in the OFC, whereas only α1, α2, γ1, and δ
were decreased in the DLPFC. These data suggest that GABAA
receptor adaptation in response to chronic ethanol drinking dif-
fered between cortical regions of the primate brain, and only
the DLPFC showed changes in the δ subunit. Likewise, the only
change observed with respect to α subunits was lowered expres-
sion, including a decrease in the α4 subtype within the OFC. The
signiﬁcance of these ﬁndings with regard to ethanol and neuroac-
tive steroid pharmacology and effects on the HPA axis requires
further investigation. However, Porcu et al. (2006) found that
the synthetic glucocorticoid dexamethasone suppressed plasma
concentrations of deoxycorticosterone, and that the efﬁcacy of
dexamethasone was negatively correlated with subsequent ethanol
self-administration using the primate model. Thus, lower gluco-
corticoid modulation of neuroactive steroid precursors may be a
risk factor for heavy drinking, particularly among individuals with
GABAA receptor subunit polymorphisms associated with greater
ethanol-like effects of neuroactive steroids (Pierucci-Lagha et al.,
2005).
Inhibition of the HPA axis by GABAergic transmission is difﬁ-
cult to reconcile with the ability of ethanol, a positive modulator
of GABAA receptors, to activate the HPA axis and increase neu-
roactive steroids in rodents. One possibility is that activation
of the sympathetic nervous system related to ethanol admin-
istration (restraint, needle poke) interacts with the effects of
ethanol to increase neuroactive steroids. Barbaccia et al. (1994)
reported that CO2 inhalation increased neuroactive steroid pre-
cursors (pregnenolone, progesterone) in rat brain, but that the
magnitude of increase was reduced after experience with han-
dling, the experimental context, and the containment apparatus,
twice daily for 5 days. A majority of studies using rats currently
include 1–2weeks of acclimation to the housing conditions, but
few include daily handling. We measured plasma pregnenolone,
progesterone, ACTH, and deoxycorticosterone in female rats that
were extremely acclimated to the procedures and found no dif-
ference between rats administered 1.0 g/kg ethanol or water (i.g.;
Helms et al., 2010). These rats had >1 year daily handling and
were gavaged 5–7 days/week in which 1.0 g/kg ethanol was admin-
istered on about half the days. Another explanation was recently
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suggested by Boyd et al. (2010a). Compared to rats fed an
isocaloric control diet, rats fed an ethanol liquid diet for 7 days
(8–10 g/kg/day) showed blunted plasmaACTH, progesterone, and
allopregnanolone when injected with 2.0 g/kg ethanol. These data
suggest tolerance develops to ethanol induction of neuroactive
steroids. However, because administering ACTH restored the efﬁ-
cacy of ethanol to increase neuroactive steroids, adrenal respon-
siveness was not impaired by chronic ethanol. Instead, chronic
exposure to ethanol also may alter steroidogenesis. For example,
injection of pregnenolone (50mg/kg, i.p.) increased allopreg-
nanolone in the cortex of alcohol-preferring P rats, but only if they
had been trained to self-administer ethanol (Besheer et al., 2010).
THE ROLE OF ENDOGENOUS NEUROACTIVE STEROIDS IN
SEX DIFFERENCES IN THE EFFECTS OF ETHANOL
Greater alcoholism risk among males is a robust observation
in humans (Chan et al., 2007; Grant et al., 2007) and non-
human primates (Vivian et al., 2002), suggesting that this sex
difference is caused directly, at least in part, by biological rather
social and behavioral differences. This sex difference is oppo-
site in adult rodents and has been related to gonadal hormones
(Vetter-O’Hagen et al., 2009; Vetter-O’Hagen and Spear, 2011), as
testosterone appears to protect adult male rodents against heavy
ethanol intake. Although contradictory results have been obtained
in studies of both species, the results of human studies gener-
ally contrast with rodent ﬁndings to suggest that testosterone is
a risk factor for heavy ethanol drinking. Testosterone is particu-
larly important in the development of male-speciﬁc maturation
in rodents and primates (Gupta et al., 1975; Sato et al., 2008).
Although present in adult females, the concentration of circu-
lating testosterone is much greater in adult male rodents (e.g.,
Pluchino et al., 2009) and primates (e.g., Muller et al., 2011), in
whom it is linked to aggressive and reproductive behavior (Sato
et al., 2008). Stålenheim et al. (1998) reported that testosterone
was associated with aggressive and antisocial behavior, which were
more prevalent in alcoholic men with a family history of alco-
holism. Among adolescent males, individuals with ≥3 symptoms
of alcohol abuse had greater testosterone (n = 13, 0.16 nmol/l)
than individuals with ≤2 symptoms (n = 451, 0.11 nmol/l). A
signiﬁcant positive correlation was found between total alcohol
abuse symptoms and testosterone after adjusting for pubertal
development (Eriksson et al., 2005). In another study using pre-
menopausal females, testosterone was elevated among individuals
with early onset alcohol abuse compared to controls, in contrast
to decreased estradiol, progesterone, androstenedione, and sex
hormone binding globulin (Pettersson et al., 1990). Consistent
with a positive correlation between alcohol drinking and circulat-
ing androgens, a more recent study of post-menopausal women
reported a signiﬁcant association between testosterone and alco-
hol intake, which had a narrow range around 1.5 drinks per day
(Wayne et al., 2008). In contradiction, however, Onland-Moret
et al. (2005) reported that testosterone concentrations were sim-
ilar amongst post-menopausal women who drank >2.5 drinks
per day and those who abstained, although the androgen DHEA
sulfate was elevated amongst the drinkers. In another correlative
study, alcohol-preferring rats had greater baseline testosterone
compared to alcohol non-preferring rats (Apter and Eriksson,
2003), which is inconsistent with the idea that testosterone pro-
tects against heavy alcohol drinking in male rodents. Few studies
have tested the hypothesis that testosterone is causally related to
ethanol drinking, and these have produced contradictory ﬁnd-
ings. First, among castrated male albino rats, those treated with
testosteronemore rapidly acquired a greater preference for ethanol
compared to those treated with estradiol, progesterone, or oil
control solution (Lakoza and Barkov, 1980). On the other hand,
castrated male Sprague-Dawley rats showed greater ethanol intake
(2.2 g/kg/2 h) compared to sham rats (1.4 g/kg/2 h), which was
decreased on average by testosterone replacement (1.75 g/kg/2 h;
Vetter-O’Hagen et al., 2011). Many procedural differences could
account for these discrepant ﬁndings, including “alcoholization”
by Lakoza and Barkov (1980) in which ethanol was administered
intraperitoneally for 2weeks prior to access to ethanol, and the use
of a sweetened solution by Vetter-O’Hagen et al. (2011). Overall, a
majority of studies suggest that testosterone inﬂuences the risk for
heavy drinking, although obviously more work is needed to deter-
mine a causal mechanism. In terms of neurosteroids, one possible
mechanism is metabolism to androsterone.
Androsterone, as reviewed above, has discriminative stimu-
lus effects similar to ethanol (monkeys, Grant et al., 2008a)
and pregnanolone (rats, Engel et al., 2001), and therefore could
increase sensitivity to ethanol via additive pharmacological effects.
Consistent with the distinct pharmacological effects of iso-
mers of neuroactive steroids, 3α,5α-androsterone, but not 3β,5α-
androsterone, is a low-potency but efﬁcacious anticonvulsant
(Kaminski et al., 2005). In one study, male volunteers, who
may have been social drinkers, had high levels of circulating
androsterone in the form of a glucuronide or sulfated conju-
gate (androsterone glucuronide, 45 ng/ml; Hsing et al., 2007),
compared to 97 pg/ml for the non-conjugated form of andros-
terone (Porcu et al., 2010). Fabre et al. (1973) reported that
both androsterone isomers (3α,5α- and 3α,5β-androsterone) were
present in lower concentrations among actively drinking (mean
BEC, 148mg/dl; 5α, 0.43mg/24 h; 5β, 0.29mg/14 h) compared
to abstinent alcoholics (5α, 0.95mg/24 h; 5β, 0.71mg/24 h) or
controls (5α, 1.4mg/24 h; 5β, 0.63mg/24 h). To our knowledge,
glucuronide or sulfate conjugates of androgens have not beenmea-
sured in heavy drinkers. If the older results of Fabre et al. (1973)
are conﬁrmed, lower levels of androgens in alcoholics could indi-
cate that the role of androgens in alcoholism is primarily as a risk
factor and not a regulator of ethanol sensitivity or consummatory
behavior, although once again, only correlative data is available.
Although present in males, progesterone concentration is two-
fold greater in reproductively fertile women (Genazzani et al.,
1998). Progesterone mediates reproductive behavior related to
pregnancy that supports fetal development such as increased con-
summatory behavior (hyperphagia, Douglas et al., 2007). Females
of old-world primates (including humans) have menstrual cycles
that occur over approximately 28–30 days. Following a 10- to
12-day follicular phase, a rapid rise in luteinizing hormone and
estrogen precedes ovulation at mid-cycle (Hotchkiss and Kno-
bil, 1994). In contrast, rodents have a 4-day estrus cycle during
which rising estradiol precedes a surge of luteinizing hormone
that coincides with the onset of proestrus and induces ovulation.
Rodent ovaries produce progesterone and progesterone-derived
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neuroactive steroids (Holzbauer, 1975) such that circulating levels
rise throughout proestrus.Approximately 12 h after the luteinizing
hormone surge, ovulation coincides with peak progesteronewhich
declines throughout estrus (Goldman et al., 2007). In primates,
progesterone mediates development of the uterine epithelium
prior to menses, but in rodents, progesterone mediates the cellular
composition of the vaginal epithelium.
The duration of exposure to endogenous neuroactive steroids
across the menstrual or estrus cycle may inﬂuence subsequent
effects of ethanol. For example, declining progesterone in the
latter half of the primate luteal phase after prolonged (about
1week) progesterone exposure could enhance the aversive effects
of ethanol withdrawal. Compared to vehicle, twice daily injection
of progesterone (5mg/kg) to rats maintained on a chronic ethanol
diet increased anxiety during ethanol withdrawal measured using
elevated plusmaze (Sharma et al., 2007). Exposure to progesterone
for several days altered the pharmacological activity of allopreg-
nanolone, and GABAA receptor subunit expression (i.e., increased
α4 and δ, decreased α1 subunits; reviewed by Smith et al., 2007;
Maguire and Mody, 2009). Indeed, tolerance to endogenous neu-
roactive steroids during the menstrual cycle and during pregnancy
correlated with changes in GABAA receptor subunit conforma-
tion and function (Turkmen et al., 2011). Differences between
rodents and primates in the time-course of endogenous prog-
esterone concentration during reproductive cycles suggests that
primate studies will provide important translational data about
the inﬂuence of ﬂuctuations in endogenous neuroactive steroids
on sensitivity to ethanol, including withdrawal from chronic
ethanol.
Consistent with sex differences in ethanol drinking and alco-
holism susceptibility, males and females differ in symptoms of
ethanol withdrawal (reviewed by Finn et al., 2010). For exam-
ple, compared to males, female rats are susceptible to seizures for
fewer days after ethanol withdrawal (Alele and Devaud, 2007).
Furthermore, withdrawal symptoms are ameliorated by GABAer-
gic neurosteroids differentially in male and female rodents (e.g.,
Devaud et al., 1998). In one study, rats’ amplitude of startle to an
auditory stimulus was slightly enhanced during withdrawal from
ethanol compared to withdrawal from a dextrose diet, but only in
male rats, not sham or ovariectomized female rats. This effect was
attenuated by progesterone (Reilly et al., 2009). In female mice,
the magnitude of handling-induced convulsions during ethanol
withdrawal was increased by ﬁnasteride, suggestingmodulation by
5α-reduced neuroactive steroids. In contrast, ﬁnasteride decreased
the magnitude of handling-induced convulsions in males (Gorin-
Meyer et al., 2007). Sex differences in anticonvulsant effects of
endogenous neurosteroids could relate to basal steroid concen-
trations. In male mice, removal of endogenous neurosteroids by
adrenalectomy increased seizure magnitude during acute ethanol
withdrawal, with no additional effect of gonadectomy. In contrast,
in female mice, both adrenalectomy and gonadectomy were nec-
essary to potentiate handling-induced convulsions during ethanol
withdrawal. In both sexes, treatment with progesterone or deoxy-
corticosterone decreased the severity of convulsions (Kaufman
et al., 2010). The absence of an effect of gonadectomy inmales sug-
gests that testosterone and its neuroactive metabolites have little
impact on seizure susceptibility during ethanol withdrawal (Finn
et al., 2010), or perhaps de novo testosterone synthesis in the brain
could be up-regulated to compensate for gonadectomy.
Withdrawal seizures in alcoholics have a relatively low inci-
dence, even among humans undergoing alcoholism treatment
(8–16%; Caetano et al., 1998). A more commonly reported with-
drawal syndrome is anxiety, often comorbid with alcohol depen-
dence in humans (Kushner et al., 2005). Repeated high doses of
ethanol followed by withdrawal from ethanol decrease the thresh-
old for seizures similar to kindling, in which seizure threshold is
reduced by repeated sub-threshold electrical activity (reviewed by
Breese et al., 2005; Rogawski, 2005). Kia et al. (2011) reported
that daily electrical stimulation of the basolateral amygdala, which
elicited convulsions, also eliminated the potentiation of tonic cur-
rents by THDOC in pyramidal neurons of the piriform cortex.
Thus, kindling resulting in basal neural excitation was associated
with decreased efﬁcacy of a neuroactive steroid to enhance tonic
currents. These in vitro data are reminiscent of the reports of cross-
tolerance to alphaxalone-induced sleep after CIE, which includes
daily withdrawal (Cagetti et al., 2003). Basal neurosteroid concen-
trations may regulate seizure threshold via modulation of tonic
currents, and changes in neurosteroid concentrations in alcoholics
that undergo abstinence could represent attempts to maintain
homeostasis of neural excitability.
ETHANOL AND NEUROACTIVE STEROID EFFECTS IN
RELATION TO CHANGES IN GABA NEUROTRANSMISSION
DURING MATURATION
The expression of GABAA receptor subunits is developmentally
regulated. However, the effect of ethanol and neuroactive steroids
on different components of GABA neurotransmission has rarely
been investigated at different maturational stages. In the cere-
bellum and thalamus of rodents, the δ subunit and associated
α subunits (α4/α6) are not expressed at birth (developmentally
equivalent to humans in the third trimester of pregnancy),but they
are progressively expressed over the ﬁrst month of life (roughly
peaking at puberty). Accordingly, in those brain regions, tonic
GABAA currents, mediated by α4/α6δ containing GABAA recep-
tors, ﬁrst appear at ∼15 days, and get progressively larger until
adulthood (Brickley et al., 1996; Wall and Usowicz, 1997; Peden
et al., 2008). In contrast, tonic GABAA currents mediated by α4δ
subunits are present at birth in the hippocampus (Holter et al.,
2010). Thus, the role of extrasynaptic GABAA receptors and tonic
inhibition in mediating neurosteroid and ethanol actions may be
broadly developmentally regulated in some brain regions (cere-
bellum/thalamus) but not in others (hippocampus). In addition
to developmental changes in GABAA receptors, there are develop-
mental changes in the transporters that establish the Cl− gradient
which is what makes GABAA receptors inhibitory in the adult
(Wang and Kriegstein, 2009). Accordingly, in the early post-natal
period in rodents (third trimester in humans) GABAA receptors
are excitatory and play a crucial role in maturation of the ner-
vous system (Eilers et al., 2001; Wang and Kriegstein, 2009). Thus,
neurosteroid and ethanol enhancement of GABAA receptors in
the human fetus is likely to be excitatory, and may interfere with
proper brain development. In the case of ethanol, such interfer-
ence may contribute to the brain damage underlying fetal alcohol
syndrome (Costa et al., 2000; Galindo et al., 2005).
Frontiers in Endocrinology | Neuroendocrine Science January 2012 | Volume 3 | Article 10 | 12
Helms et al. Neurosteroid effects on sensitivity to ethanol
As well as the broad developmental changes in the GABAer-
gic system that likely affect the impact of neurosteroids and
ethanol, there are speciﬁc developmental changes in the GABAer-
gic system that may inﬂuence responses to neurosteroids and
ethanol. Speciﬁcally, GABA neurotransmission appears to be dis-
tinct during puberty (post-natal days 35–45 in mice), which
may contribute to the vulnerability of adolescents to alcohol
abuse and dependence (Grant and Dawson, 1997). Shen et al.
(2010) reported 300 and 700% greater α4 and δ subunit expres-
sion, respectively, on dendritic spine (not shaft) membranes of
CA1 pyramidal cells in pubertal compared to pre-pubertal and
adult female mice. Additionally, whereas allopregnanolone poten-
tiated GABA-induced currents and decreased anxiety in adult
rodents (Finn and Purdy, 2007), allopregnanolone increased anx-
iety and decreased tonic GABA-induced currents (CA1 pyrami-
dal cells) in female mice during puberty. This differential effect
of allopregnanolone was related to a basal outward Cl− cur-
rent at α4βδ receptors during puberty, as opposed to inward
during adulthood (Shen et al., 2007). Pyramidal cells of puber-
tal mice were more sensitive to currents induced by the α4
and δ subunit-selective agonist gaboxadol, consistent with the
unique subunit expression occurring during puberty. Allopreg-
nanolone (30 nM) facilitated long-term potentiation and spatial
learning in pubertal mice, but decreased long-term potentiation
in pre-pubertal mice (Shen et al., 2010). A pattern of ethanol
exposure in rats meant to model binge drinking in adolescence
(3 g/kg/day, 8 days of injections with two intervening saline injec-
tions) heightened HPA axis reactivity to stress (acute ethanol) as
adults (Przybycien-Szymanska et al., 2011). Ethanol exposure dur-
ing the sensitive pubertal period could disrupt the maturation
of stress response systems including neurosteroid regulation of
homeostasis, perhaps altering ethanol sensitivity, and increasing
risk of alcoholism.
FUTURE DIRECTIONS
An area of research needing attention is the contribution of
neurosteroids to ethanol effects on sleep, an essential process
regulating mood and responses to stress that is disrupted in alco-
holism (Brower, 2003). A key brain structure involved in sleep
is the ventrolateral preoptic area of the hypothalamus, which
sends galanin and GABA projections to brainstem arousal nuclei
to maintain sleep, with reverse inhibitory projections maintain-
ing wakefulness (Harrison, 2007). During the ﬁrst half of a
sleep bout, high doses of ethanol decrease the latency to sleep
onset, increase slow-wave sleep and decrease rapid eye move-
ment (REM) sleep (young adult women; Williams et al., 1983),
whereas the opposite effects are observed in the last half of a
sleep bout (Feige et al., 2006). Sleep deprivation interacts with
ethanol to potentiate daytime sleepiness and performance impair-
ments due to ethanol (Roehrs and Roth, 2001). Both alcoholic
men and women were reported to have more REM sleep, and
less slow-wave sleep, compared to controls, with altered electroen-
cephalograms during non-REM sleep (Gann et al., 2001; Colrain
et al., 2010). A recent study found that moderately intoxicat-
ing doses of ethanol are associated with greater sleep disruption
in women compared to men (Arnedt et al., 2011). It is tempt-
ing to speculate that neuroactive steroids could be a factor in
sex differences in ethanol-induced disruption of sleep. Only a
few studies, however, have investigated neuroactive steroid inﬂu-
ences on sleep. Pregnenolone sulfate (47.5mg/kg) increased REM
sleep in rats without affecting slow-wave sleep or wakefulness
(Darnaudéry et al., 1999). Administration of 15mg/kg allopreg-
nanolone per day for 5 days to rats dramatically altered the
timing of sleep stages including decreased non-REM episodes,
decreased latency to non-REM sleep, and increased latency to
REM sleep (Damianisch et al., 2001). The effects of acute allo-
pregnanolone and THDOC are similar, both decreasing sleep
latency and increasing the duration of transition between non-
REM and REM sleep (Müller-Preuss et al., 2002). Likewise,
allopregnanolone (7.5 and 15mg/kg) decreased the latency to
sleep and increased the time in transition between non-REM
and REM sleep (rats, Lancel et al., 1997). Pregnenolone sulfate
regulated the percentage of REM sleep, but not non-REM or
wakefulness, when infused into the pedunculopontine tegmen-
tum, a component of the reticular formation (Darbra et al.,
2004). In contrast, up to 100mg/kg dehydroepiandrosterone sul-
fate does not affect sleep cycles, but affects electroencephalograms
associated with non-REM sleep (Schiffelholz et al., 2000). Addi-
tional studies are needed to determine whether neurosteroid
mechanisms are involved in ethanol inﬂuences on sleep, and
whether neuroactive steroids could ameliorate sleep deﬁcits in
alcoholics.
SUMMARY
Investigation of the effects of neuroactive steroids has come a long
way since the ﬁrst realizations of their shared receptor mecha-
nisms with ethanol. These common receptor mechanisms (e.g.,
GABAA, NMDA receptors) mediate neurotransmission in ubiqui-
tous neural pathways regulating excitation and inhibition across
many brain areas. The diversity of neuronal types regulated by
GABA and glutamate and expressing receptors for these neu-
rotransmitters accounts for the multiple behavioral effects of
ethanol and their modulation by neuroactive steroids. Neuroac-
tive steroids appear to be able to modify many of the behaviors
affected by ethanol along a continuum broadly bounded by exci-
tation (anxiety or vigilance, convulsions, perhaps impulsivity)
and inhibition (anxiolysis, decreased seizure threshold, sedation,
ataxia). The endogenous role of neuroactive steroids in regulat-
ing these behaviors provides a window into the abnormalities
observed in alcoholics. The strongest candidates for the endoge-
nous ligands acting at the receptor systems mediating ethanol
effects are neuroactive steroids, although not all of the receptor
systems were covered in this review (e.g., 5-hydroxytryptamine
receptors, sigma receptors). Additional evidence for neuroactive
steroids as endogenous alcohols comes from their common meta-
bolic substrates (Figure 1). Although we have learned much, it
has only been less than 30 years since Harrison and Simmond’s
(1984) study of the anesthetic actions of alphaxalone, and plenty
of work remains to be done. For example, clarifying the func-
tions of neuroactive steroids in maturation is likely to reveal
the mechanisms for abnormalities induced by prenatal alcohol.
It has been 20 years since the initial studies linking neuroactive
steroids to the HPA axis (e.g., Purdy et al., 1991). The HPA axis
may serve as a bridge between peripheral organs, the brain, and
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ultimately behavior to for optimal energy utilization depend-
ing on environmental conditions. Neuroactive steroids may be
a central mechanism by which these environmental conditions
are signaled to the brain, HPA axis, and the rest of the body.
The signiﬁcance of neuroactive steroids for a variety of physio-
logical and behavioral processes affected by ethanol suggests that
they should continue to be a focus of research for alcoholism
therapies.
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